Daptomycin
Rank #287 of 500 drugs by total cost
Data: CMS Medicare Part D, 2023 (most current available) · Updated March 2026
$41.2M
Total Cost
41,245
Total Claims
$41.2M
Total Cost
1,296
Prescribers
$1,000
Cost per Claim
4,770
Beneficiaries
41,246
30-Day Fills
$32K
Avg Cost/Provider
32
Avg Claims/Provider
Share of Medicare Part D Spending
0.01%
of total Medicare Part D spending
$41.2M of $275.65B
Top Prescribers by Cost
Top 10 prescribers of $41.2M total
🔎 Data Overview
Average cost of $8,646 per patient per year. Medications at this price point significantly impact patient out-of-pocket costs and Medicare spending.
Insights generated from CMS data analysis. Statistical patterns are not accusations — always consider clinical context.
Top Prescribers of Daptomycin
| # | Provider | Specialty | Location | Claims | Cost |
|---|---|---|---|---|---|
| 1 | Alan Chapman | Infectious Disease | Houston, TX | 393 | $743K |
| 2 | Jessica Johnson | Internal Medicine | Morgantown, WV | 500 | $570K |
| 3 | J. Duke | General Surgery | Dothan, AL | 605 | $549K |
| 4 | Christopher Bettacchi | Infectious Disease | Dallas, TX | 425 | $418K |
| 5 | Yama Osmanzai | Internal Medicine | Myrtle Beach, SC | 161 | $380K |
| 6 | Raymond Bandy | Internal Medicine | Mountain Home, AR | 223 | $364K |
| 7 | William Holland | Internal Medicine | Amarillo, TX | 198 | $358K |
| 8 | Emma Dishner | Infectious Disease | Dallas, TX | 173 | $309K |
| 9 | Shehzadi Nagra | Infectious Disease | Wichita Falls, TX | 165 | $244K |
| 10 | Dhiresh Joshi | Infectious Disease | Las Vegas, NV | 202 | $244K |
| 11 | Anita Scribner | Infectious Disease | Longview, TX | 208 | $229K |
| 12 | Bachir Younes | Infectious Disease | Palm Desert, CA | 269 | $229K |
| 13 | Vijay Kolli | Infectious Disease | Mustang, OK | 126 | $216K |
| 14 | Jorge Zuniga | Infectious Disease | Houston, TX | 172 | $213K |
| 15 | Muddasar Chaudry | Infectious Disease | Salem, VA | 122 | $208K |
Top prescribers ranked by total cost for this drug in 2023.
Related Drugs by Cost
| # | Drug | Total Cost | Claims |
|---|---|---|---|
| 284 | Latanoprostene Bunod (Vyzulta) | $41.6M | 92,705 |
| 285 | Travoprost (Travoprost) | $41.5M | 178,599 |
| 286 | Alendronate Sodium (Alendronate Sodium) | $41.4M | 3,414,824 |
| 287 | Daptomycin (Daptomycin) | $41.2M | 41,245 |
| 288 | Pitavastatin Calcium (Livalo) | $40.8M | 69,636 |
| 289 | Bromfenac Sodium (Prolensa) | $40.8M | 121,284 |
| 290 | Suvorexant (Belsomra) | $40.7M | 87,327 |
Related Analysis
Data from CMS Medicare Part D Prescriber-Drug Public Use File, 2023. Methodology